UBS Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-84,455
Closed -$266K 8034
2020
Q3
$266K Buy
84,455
+2,760
+3% +$8.69K ﹤0.01% 3821
2020
Q2
$238K Sell
81,695
-52,250
-39% -$152K ﹤0.01% 3888
2020
Q1
$378K Sell
133,945
-23,210
-15% -$65.5K ﹤0.01% 3438
2019
Q4
$510K Sell
157,155
-1,186,838
-88% -$3.85M ﹤0.01% 3879
2019
Q3
$2.9M Buy
1,343,993
+394,537
+42% +$852K ﹤0.01% 2310
2019
Q2
$2.98M Buy
949,456
+117,036
+14% +$368K ﹤0.01% 2211
2019
Q1
$3.1M Sell
832,420
-420,346
-34% -$1.56M ﹤0.01% 2105
2018
Q4
$3.63M Buy
1,252,766
+324,428
+35% +$941K ﹤0.01% 1953
2018
Q3
$2.44M Buy
928,338
+171,437
+23% +$451K ﹤0.01% 2462
2018
Q2
$1.77M Sell
756,901
-172,758
-19% -$404K ﹤0.01% 2629
2018
Q1
$2.73M Buy
929,659
+186,343
+25% +$548K ﹤0.01% 2313
2017
Q4
$2.04M Sell
743,316
-89,480
-11% -$245K ﹤0.01% 2517
2017
Q3
$2.82M Buy
832,796
+110,683
+15% +$375K ﹤0.01% 2205
2017
Q2
$1.78M Sell
722,113
-47,118
-6% -$116K ﹤0.01% 2503
2017
Q1
$1.75M Buy
769,231
+723,977
+1,600% +$1.64M ﹤0.01% 2440
2016
Q4
$96K Sell
45,254
-4,656
-9% -$9.88K ﹤0.01% 4440
2016
Q3
$167K Buy
49,910
+5,081
+11% +$17K ﹤0.01% 3852
2016
Q2
$140K Sell
44,829
-40,387
-47% -$126K ﹤0.01% 3986
2016
Q1
$284K Buy
85,216
+34,639
+68% +$115K ﹤0.01% 3537
2015
Q4
$180K Buy
50,577
+9,621
+23% +$34.2K ﹤0.01% 3843
2015
Q3
$206K Sell
40,956
-48,940
-54% -$246K ﹤0.01% 3694
2015
Q2
$577K Buy
89,896
+14,746
+20% +$94.6K ﹤0.01% 3158
2015
Q1
$529K Sell
75,150
-23,968
-24% -$169K ﹤0.01% 3189
2014
Q4
$764K Buy
+99,118
New +$764K ﹤0.01% 2894